Fresenius Medical Care Needs U.S. Volume Growth to Win Over Investors — Market Talk

Fresenius Medical Care has made progress on its cost-savings plan, but it might need to return to U.S. volume growth to win over investors, Berenberg analysts say in a research note. The German dialysis specialist has delivered around 920 million euros in savings out of a target of 1.2 billion euro…